patients with liver damage or blood dyscrasias. Extensive clinical use and laboratory tests have revealed parnate high dose evidence of liver toxicity or blood dyscrasias due to tranylcypromine parnate high dose Because parnate high dose cases of hepatitis have parnate high dose reported, it is recommended that patients with known liver.

retention, sweating, impotence, tinnitus, muscle spasm and tremors, paresthesia, skin rash and mild jaundice have been reported parnate high dose rare instances.Serious hypertensive crises may occur in patients receiving tranylcypromine. These responses parnate high dose not parnate high dose dose related and are parnate high dose parnate high dose a distinctive reaction characterized by some or all of the following parnate high dose occipital headache which parnate high dose radiate frontally, palpitation, neck stiffness or soreness, nausea or vomiting, sweating (sometimes with fever and sometimes with cold, clammy skin) parnate high dose photophobia. Either tachycardia or bradycardia may be parnate high dose and associated constricting chest pain and dilated pupils may occur. Intracranial bleeding, sometimes fatal in outcome, has been parnate high dose in association with this parnate high dose increase in blood pressure.If parnate high dose hypertensive reaction occurs, discontinue the drug parnate high dose institute hypotensive therapy. Headache tends to abate as blood parnate high dose lowers. Phentolamine mesylate (5 mg i.v.) is parnate high dose for use recommended.

tasks, such as parnate high dose a car or operating machinery.Some people parnate high dose physically dependent on Parnate and experience.